BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34880044)

  • 1. Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort study.
    Cusimano MC; Chiu M; Ferguson SE; Moineddin R; Aktar S; Liu N; Baxter NN
    BMJ; 2021 Dec; 375():e067528. PubMed ID: 34880044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.
    Cusimano MC; Ferguson SE; Moineddin R; Chiu M; Aktar S; Liu N; Baxter NN
    Am J Obstet Gynecol; 2022 Feb; 226(2):220.e1-220.e26. PubMed ID: 34563499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
    Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
    JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
    Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
    Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice variation in bilateral salpingo-oophorectomy at benign abdominal hysterectomy: a population-based study.
    Cusimano MC; Moineddin R; Chiu M; Ferguson SE; Aktar S; Liu N; Baxter NN
    Am J Obstet Gynecol; 2021 Jun; 224(6):585.e1-585.e30. PubMed ID: 33359174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk after hysterectomy with and without salpingo-oophorectomy for benign indications.
    Chow S; Raine-Bennett T; Samant ND; Postlethwaite DA; Holzapfel M
    Am J Obstet Gynecol; 2020 Dec; 223(6):900.e1-900.e7. PubMed ID: 32585221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hysterectomy status and all-cause mortality in a 21-year Australian population-based cohort study.
    Wilson LF; Pandeya N; Byles J; Mishra GD
    Am J Obstet Gynecol; 2019 Jan; 220(1):83.e1-83.e11. PubMed ID: 30312584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of hysterectomy with bilateral salpingo-oophorectomy: a systematic review and meta-analysis.
    Hassan H; Allen I; Sofianopoulou E; Walburga Y; Turnbull C; Eccles DM; Tischkowitz M; Pharoah P; Antoniou AC
    Am J Obstet Gynecol; 2024 Jan; 230(1):44-57. PubMed ID: 37364803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
    Terra L; Beekman MJ; Engelhardt EG; Heemskerk-Gerritsen BAM; van Beurden M; Roeters van Lennep JE; van Doorn HC; de Hullu JA; Van Dorst EBL; Mom CH; Slangen BFM; Gaarenstroom KN; van der Kolk LE; Collée JM; Wevers MR; Ausems MGEM; Van Engelen K; van de Beek I; Berger LPV; van Asperen CJ; Gomez Garcia EB; Maas AHEM; Hooning MJ; Aaronson NK; Mourits MJE; van Leeuwen FE
    Am J Obstet Gynecol; 2023 Apr; 228(4):440.e1-440.e20. PubMed ID: 36403862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral salpingo-oophorectomy at the time of benign hysterectomy among females with disabilities: a population-based cross-sectional study.
    Scime NV; Brown HK; Metcalfe A; Simpson AN; Brennand EA
    Am J Obstet Gynecol; 2023 Dec; 229(6):658.e1-658.e17. PubMed ID: 37544349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer.
    Cham S; Chen L; St Clair CM; Hou JY; Tergas AI; Melamed A; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2019 Jun; 220(6):571.e1-571.e8. PubMed ID: 30771346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy.
    Chan JK; Urban R; Capra AM; Jacoby V; Osann K; Whittemore A; Habel LA
    Obstet Gynecol; 2014 Jan; 123(1):65-72. PubMed ID: 24463665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy.
    Ayres C; Ratnayake G; McNally O; Quinn M
    Int J Gynecol Cancer; 2017 May; 27(4):703-707. PubMed ID: 28399030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
    Finch AP; Lubinski J; Møller P; Singer CF; Karlan B; Senter L; Rosen B; Maehle L; Ghadirian P; Cybulski C; Huzarski T; Eisen A; Foulkes WD; Kim-Sing C; Ainsworth P; Tung N; Lynch HT; Neuhausen S; Metcalfe KA; Thompson I; Murphy J; Sun P; Narod SA
    J Clin Oncol; 2014 May; 32(15):1547-53. PubMed ID: 24567435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations.
    Smith MJ; Gerber D; Olsen A; Khouri OR; Wang Y; Liu M; Smith J; Pothuri B
    Am J Obstet Gynecol; 2021 Nov; 225(5):508.e1-508.e10. PubMed ID: 34171390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists.
    Blustein P; Werner SR; Uppalapati P; Leung TM; Husk GA; Pereira EB; Whyte JS; Villella JA
    Am J Obstet Gynecol; 2023 Sep; 229(3):280.e1-280.e8. PubMed ID: 37308046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of stroke after bilateral salpingo-oophorectomy at hysterectomy for benign diseases: A nationwide cohort study.
    Lai JC; Chou YJ; Huang N; Chen HH; Wang KL; Wang CW; Shen IH; Chang HC
    Maturitas; 2018 Aug; 114():27-33. PubMed ID: 29907243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS.
    Taylor JA; Burnell M; Ryan A; Karpinskyj C; Kalsi JK; Taylor H; Apostolidou S; Sharma A; Manchanda R; Woolas R; Campbell S; Parmar M; Singh N; Jacobs IJ; Menon U; Gentry-Maharaj A
    BJOG; 2022 Jan; 129(1):110-118. PubMed ID: 34555263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
    Domchek SM; Friebel TM; Singer CF; Evans DG; Lynch HT; Isaacs C; Garber JE; Neuhausen SL; Matloff E; Eeles R; Pichert G; Van t'veer L; Tung N; Weitzel JN; Couch FJ; Rubinstein WS; Ganz PA; Daly MB; Olopade OI; Tomlinson G; Schildkraut J; Blum JL; Rebbeck TR
    JAMA; 2010 Sep; 304(9):967-75. PubMed ID: 20810374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.